Quantcast

Latest Dana-Farber Cancer Institute Stories

2013-12-09 14:08:58

Bortezomib (Velcade) reduces GVHD, boosts survival Adding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem-cell transplants from mismatched and unrelated donors, according to researchers from Dana-Farber Cancer Institute. In a new phase 2 trial, patients treated with bortezomib had lower rates of severe acute GVHD and treatment-related mortality, and experienced better one-year overall...

2013-12-09 10:45:08

Patients with myelodysplastic syndromes (MDS) who were as old as 74 fared as well with stem cell transplantation as did patients in the 60-to-65 age range, according to a study from Dana-Farber Cancer Institute presented at the annual meeting of the American Society of Hematology. "This is good evidence that age alone should not limit who should get a transplant for MDS," said Gregory Abel, MD, MPH, a medical oncologist at Dana-Farber. "Calendar age is less important than other measures,...

2013-10-27 23:00:49

A study lead by scientists at University of Colorado Cancer Center and Dana-Farber Cancer Institute in Boston has uncovered a new sub-type of lung cancer. AURORA, Colo. (PRWEB) October 27, 2013 A study lead by scientists at University of Colorado Cancer Center and Dana-Farber Cancer Institute in Boston has uncovered a new sub-type of lung cancer. The study revealed a gene fusion - a forced merger of two normally separate genes – that spurs the cells to divide rapidly causing non-small...

2013-10-11 12:01:09

A research team from Dana-Farber/Boston Children's Cancer and Blood Disorders Center and other institutions has discovered a new genetic target for potential therapy of sickle cell disease (SCD). The target, called an enhancer, controls a molecular switch in red blood cells called BCL11A that, in turn, regulates hemoglobin production. The researchers—led by Daniel Bauer, MD, PhD, and Stuart Orkin, MD, of Dana-Farber/Boston Children's—reported their findings today in Science. Prior...

Cancer Survival Rates Higher For Married Patients
2013-09-24 04:41:56

[ Watch the Video: Marriage A Real Lifesaver For Cancer Patients ] redOrbit Staff & Wire Reports - Your Universe Online Marriage can be a real lifesaver for cancer patients, according to new research showing that patients who have a husband or wife at the time of diagnosis tend to live longer than their unwed counterparts. The study, which was published online Monday in the Journal of Clinical Oncology, reported that married cancer patients were 20 percent less likely to die from...

2013-09-19 13:02:38

A team of researchers, including those from Dana-Farber Cancer Institute, Brigham and Women's Hospital and the Harvard School of Public Health, will be reporting study findings that lend powerful scientific backing to the recommendation that people receive a colonoscopy screening to prevent colorectal cancer. By analyzing medical data from nearly 90,000 people in two major health studies, the researchers found that participants who received either a colonoscopy or sigmoidoscopy exam –...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related